ArticleInternational journal of molecular medicine2018

A proteomic analysis of chemoresistance development via sequential treatment with doxorubicin reveals novel players in MCF‑7 breast cancer cells.

Ann-Katrin Sommer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.